Hyaluronidase for pharmacologic vitreolysis
- PMID: 19494648
- DOI: 10.1159/000223941
Hyaluronidase for pharmacologic vitreolysis
Abstract
Various pharmacologic vitreolysis agents, including hyaluronidase, urea, plasmin, dispase, tissue plasminogen activator and chondroitinase have been tested. Pharmacologic vitreolysis can avoid the complications of surgery such as cataract, endophthalmitis, retinal hemorrhage, tear or detachment, and anesthesia related complications. Hyaluronan is a major macromolecule of vitreous. It is a long, unbranched polymer of repeating disaccharide (glucuronic acid beta (1,3)-N-acetylglucosamine) moieties linked by beta 1-4 bonds. Hyaluronan is covalently linked to a protein core, to form a proteoglycan. It plays a pivotal role in stabilizing the vitreous gel. Hyaluronidase cleaves glycosidic bonds of hyaluronic acid and, to a variable degree, other acid mucopolysaccharides of the connective tissue. Dissolution of the hyaluronic acid and collagen complex results in decreased viscosity of the extracellular matrix. This in turn increases the diffusion rate of erythrocytes and exudates along with phagocytes through the vitreous and facilitates red blood cell lysis and phagocytosis.
Copyright 2009 S. Karger AG, Basel.
Similar articles
-
Molecular biology of pharmacologic vitreolysis.Trans Am Ophthalmol Soc. 2005;103:473-94. Trans Am Ophthalmol Soc. 2005. PMID: 17057814 Free PMC article.
-
Pharmacologic vitreolysis.Dev Ophthalmol. 2007;39:149-156. doi: 10.1159/000098505. Dev Ophthalmol. 2007. PMID: 17245084
-
Is pharmacologic vitreolysis brewing?Retina. 2002 Feb;22(1):1-3. doi: 10.1097/00006982-200202000-00001. Retina. 2002. PMID: 11884870 No abstract available.
-
Pharmacological vitrectomy.Semin Ophthalmol. 2000 Mar;15(1):51-61. doi: 10.3109/08820530009037851. Semin Ophthalmol. 2000. PMID: 10749315 Review.
-
Vitreous as a substrate for vitreolysis.Dev Ophthalmol. 2009;44:7-19. doi: 10.1159/000223939. Epub 2009 Jun 3. Dev Ophthalmol. 2009. PMID: 19494647 Review.
Cited by
-
Densification: Hyaluronan Aggregation in Different Human Organs.Bioengineering (Basel). 2022 Apr 5;9(4):159. doi: 10.3390/bioengineering9040159. Bioengineering (Basel). 2022. PMID: 35447719 Free PMC article. Review.
-
Clinical Applications of Hyaluronidase.Adv Exp Med Biol. 2019;1148:255-277. doi: 10.1007/978-981-13-7709-9_12. Adv Exp Med Biol. 2019. PMID: 31482503 Review.
-
β-elimination of hyaluronate by red king crab hyaluronidase.Sci Rep. 2021 Nov 19;11(1):22600. doi: 10.1038/s41598-021-01890-3. Sci Rep. 2021. PMID: 34799594 Free PMC article.
-
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy of Hyaluronidase in Preventing Perineal Trauma in Nulliparous Women.Yonsei Med J. 2020 Jan;61(1):79-84. doi: 10.3349/ymj.2020.61.1.79. Yonsei Med J. 2020. PMID: 31887803 Free PMC article. Clinical Trial.
-
Hyaluronidase: from clinical applications to molecular and cellular mechanisms.Eur J Med Res. 2016 Feb 13;21:5. doi: 10.1186/s40001-016-0201-5. Eur J Med Res. 2016. PMID: 26873038 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
